Intrinsic Value

MoonLake Immunotherapeutics (MLTX)

$50.23

+0.02 (+0.04%)

Enterprise Value -
Net Debt -447.47
Equity Value -
Shares Outstanding 49.12
Equity Value Per Share -



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt